226 related articles for article (PubMed ID: 19969511)
1. New specific molecular targets for radio-chemotherapy of rectal cancer.
Snipstad K; Fenton CG; Kjaeve J; Cui G; Anderssen E; Paulssen RH
Mol Oncol; 2010 Feb; 4(1):52-64. PubMed ID: 19969511
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.
Ghadimi BM; Grade M; Difilippantonio MJ; Varma S; Simon R; Montagna C; Füzesi L; Langer C; Becker H; Liersch T; Ried T
J Clin Oncol; 2005 Mar; 23(9):1826-38. PubMed ID: 15774776
[TBL] [Abstract][Full Text] [Related]
3. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment transcriptional profiling for predicting response to neoadjuvant chemoradiotherapy in rectal adenocarcinoma.
Brettingham-Moore KH; Duong CP; Greenawalt DM; Heriot AG; Ellul J; Dow CA; Murray WK; Hicks RJ; Tjandra J; Chao M; Bui A; Joon DL; Thomas RJ; Phillips WA
Clin Cancer Res; 2011 May; 17(9):3039-47. PubMed ID: 21224373
[TBL] [Abstract][Full Text] [Related]
5. Early dynamic transcriptomic changes during preoperative radiotherapy in patients with rectal cancer: a feasibility study.
Supiot S; Gouraud W; Campion L; Jezéquel P; Buecher B; Charrier J; Heymann MF; Mahé MA; Rio E; Chérel M
World J Gastroenterol; 2013 Jun; 19(21):3249-54. PubMed ID: 23745026
[TBL] [Abstract][Full Text] [Related]
6. A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients.
Agostini M; Zangrando A; Pastrello C; D'Angelo E; Romano G; Giovannoni R; Giordan M; Maretto I; Bedin C; Zanon C; Digito M; Esposito G; Mescoli C; Lavitrano M; Rizzolio F; Jurisica I; Giordano A; Pucciarelli S; Nitti D
Cancer Biol Ther; 2015; 16(8):1160-71. PubMed ID: 26023803
[TBL] [Abstract][Full Text] [Related]
7. Radiation induces different changes in expression profiles of normal rectal tissue compared with rectal carcinoma.
Nagtegaal ID; Gaspar CG; Peltenburg LT; Marijnen CA; Kapiteijn E; van de Velde CJ; Fodde R; van Krieken JH
Virchows Arch; 2005 Feb; 446(2):127-35. PubMed ID: 15602683
[TBL] [Abstract][Full Text] [Related]
8. High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer.
Flanagan L; Kehoe J; Fay J; Bacon O; Lindner AU; Kay EW; Deasy J; McNamara DA; Prehn JH
Radiat Oncol; 2015 Jun; 10():131. PubMed ID: 26071313
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.
Uzcudun AE; Batlle JF; Velasco JC; Sánchez Santos ME; Carpeño Jde C; Grande AG; Juberías AM; Piñeiro EH; Olivar LM; García AG
Dis Colon Rectum; 2002 Oct; 45(10):1349-58. PubMed ID: 12394434
[TBL] [Abstract][Full Text] [Related]
10. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
Yao YF; Du CZ; Chen N; Chen P; Gu J
Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer.
Rödel C; Grabenbauer GG; Papadopoulos T; Bigalke M; Günther K; Schick C; Peters A; Sauer R; Rödel F
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):294-303. PubMed ID: 11872273
[TBL] [Abstract][Full Text] [Related]
12. Locally advanced rectal cancer patients receiving radio-chemotherapy: a novel clinical-pathologic score correlates with global outcome.
Berardi R; Mantello G; Scartozzi M; Del Prete S; Luppi G; Martinelli R; Fumagalli M; Grillo-Ruggieri F; Bearzi I; Mandolesi A; Marmorale C; Cascinu S
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1437-43. PubMed ID: 19386440
[TBL] [Abstract][Full Text] [Related]
13. p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma.
Luna-Perez P; Arriola EL; Cuadra Y; Alvarado I; Quintero A
Ann Surg Oncol; 1998; 5(3):203-8. PubMed ID: 9607618
[TBL] [Abstract][Full Text] [Related]
14. Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.
Palma P; Cuadros M; Conde-Muíño R; Olmedo C; Cano C; Segura-Jiménez I; Blanco A; Bueno P; Ferrón JA; Medina P
PLoS One; 2013; 8(9):e74034. PubMed ID: 24040155
[TBL] [Abstract][Full Text] [Related]
15. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T
J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739
[TBL] [Abstract][Full Text] [Related]
16. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.
Kim IJ; Lim SB; Kang HC; Chang HJ; Ahn SA; Park HW; Jang SG; Park JH; Kim DY; Jung KH; Choi HS; Jeong SY; Sohn DK; Kim DW; Park JG
Dis Colon Rectum; 2007 Sep; 50(9):1342-53. PubMed ID: 17665260
[TBL] [Abstract][Full Text] [Related]
17. Rectal cancer: changing patterns of referral for radiation therapy 1982-1997.
Stevens G; Firth I; Solomon M; Saw R; Glenn D; Eyers A; West R
Aust N Z J Surg; 2000 Aug; 70(8):553-9. PubMed ID: 10945546
[TBL] [Abstract][Full Text] [Related]
18. APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling.
Petty RD; Samuel LM; Murray GI; MacDonald G; O'Kelly T; Loudon M; Binnie N; Aly E; McKinlay A; Wang W; Gilbert F; Semple S; Collie-Duguid ES
BMC Cancer; 2009 Dec; 9():434. PubMed ID: 20003335
[TBL] [Abstract][Full Text] [Related]
19. High MUC2 immunohistochemical expression is a predictor of poor response to preoperative radiochemotherapy (RCT) in rectal adenocarcinoma.
Ambrosini-Spaltro A; Salvi F; Miglio R; Liguori L; Fabbri C; Piemontese A; Martelli O; Frezza GP; Foschini MP
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):227-31. PubMed ID: 18301248
[TBL] [Abstract][Full Text] [Related]
20. [Proliferation and apoptosis before and after preoperative simultaneous radiochemotherapy of rectal carcinomas].
Tannapfel A; Nüsslein S; Katalinic A; Köckerling F; Wittekind C; Fietkau R
Strahlenther Onkol; 1998 Jun; 174(6):295-9. PubMed ID: 9645209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]